FdaApplication
ANDA 205761
Identifiers
- fda_app_no: ANDA205761
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2017-02-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RABEPRAZOLE SODIUM | RABEPRAZOLE SODIUM | 20MG | TABLET, DELAYED RELEASE;ORAL |
1 product